OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation
Camilla Pecoraro, Michele De Franco, Daniela Carbone, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115134-115134
Closed Access | Times Cited: 33
Camilla Pecoraro, Michele De Franco, Daniela Carbone, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115134-115134
Closed Access | Times Cited: 33
Showing 26-50 of 33 citing articles:
The BET inhibitor sensitivity is associated with the expression level of CDC25B in pancreatic cancer models
Aubrey L. Miller, Patrick L. Garcia, Rebecca B. Vance, et al.
Cancer Drug Resistance (2024)
Open Access
Aubrey L. Miller, Patrick L. Garcia, Rebecca B. Vance, et al.
Cancer Drug Resistance (2024)
Open Access
Exploring the Anticancer Potential of Triazine Derivatives: An Outlook of Designing Strategies, Docking Studies, and Structure‐Activity Relationships (SAR)
B V Manjushree, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
ChemistrySelect (2024) Vol. 9, Iss. 41
Open Access
B V Manjushree, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
ChemistrySelect (2024) Vol. 9, Iss. 41
Open Access
Triazines, tetrazines, and fused ring polyaza systems
Pierre Audebert, Vincent Sol
Progress in heterocyclic chemistry (2024), pp. 395-420
Closed Access
Pierre Audebert, Vincent Sol
Progress in heterocyclic chemistry (2024), pp. 395-420
Closed Access
Identification of a Selective Pyruvate Dehydrogenase Kinase 1 (Pdhk1) Chemical Probe by Virtual Screening
Mason A. Baber, M. Gough, Larisa Yeomans, et al.
(2024)
Closed Access
Mason A. Baber, M. Gough, Larisa Yeomans, et al.
(2024)
Closed Access
Exploring PDK3 inhibition in lung cancer through drug repurposing for potential therapeutic interventions
Zeba Firdos Khan, Aanchal Rathi, Afreen Khan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Zeba Firdos Khan, Aanchal Rathi, Afreen Khan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Identification of a Selective Pyruvate Dehydrogenase Kinase 1 (PDHK1) Chemical Probe by Virtual Screening
Mason A. Baber, M. Gough, Larisa Yeomans, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117210-117210
Closed Access
Mason A. Baber, M. Gough, Larisa Yeomans, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117210-117210
Closed Access
An Exploration of the Inhibitory Mechanism of Rationally Screened Benzofuran-1,3,4-Oxadiazoles and-1,2,4-Triazoles as Inhibitors of NS5B RdRp Hepatitis C Virus through Pharmacoinformatic Approaches
Ali Irfan, Shah Faisal, Sajjad Ahmad, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3085-3085
Open Access | Times Cited: 1
Ali Irfan, Shah Faisal, Sajjad Ahmad, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3085-3085
Open Access | Times Cited: 1
In Silico Insights Toward the Exploration of Adenosine Receptors Ligand Recognition
Davide Bassani, Stefano Moro
Topics in medicinal chemistry (2023), pp. 275-315
Closed Access
Davide Bassani, Stefano Moro
Topics in medicinal chemistry (2023), pp. 275-315
Closed Access
Colon Metastasis from Pancreatic Cancer: A Case Report
Nan Meng, Ping Han, Liwei Liu, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 739-744
Open Access
Nan Meng, Ping Han, Liwei Liu, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 739-744
Open Access
